Instagram has renamed its “AI creator” label to “AI-generated profile” for accounts built around AI-generated people. AI persona accounts that fail to disclose their synthetic identity may face reduced reach and lose recommendation eligibility, with appeals available through Account Status. Human creators who merely use AI tools in their creative process do not need the profile label.creators.instagram.com ↗
Cloudflare launched Adaptive Intelligence, a bot-detection engine that continuously adapts to changing attack methods. The engine retrains on live traffic and jointly evaluates signals including TLS fingerprints, session behaviour, request structures and client telemetry. Enterprise customers can access it by enabling automatic machine-learning updates in the Bot Management dashboard.blog.cloudflare.com ↗
Open-source AI assistant OpenClaw has released OpenClaw 2.0, the largest update in its history, built by 933 contributors and comprising over 16,000 pull requests. The release simplifies setup, rebuilds the browser app from the ground up, and introduces shared cloud sessions that let teams collaborate live on the same task. The nearly two-month development stretch prioritized a smooth transition for existing users over shipping quickly.openclaw.ai ↗
AI imageApple has released the eighth developer beta of iOS 27 and iPadOS 27, arriving one week after beta 7. At this late stage, the update focuses mainly on bug fixes, performance tweaks, and refinements to Siri AI and the Liquid Glass design rather than new features. The public release is expected shortly after Apple's iPhone event in September.developer.apple.com ↗
AI imageLinus Torvalds released the first Linux 7.3 release candidate (RC1), closing the merge window for the new kernel cycle. The update brings extensive hardware, file-system and driver changes, with AMD’s next-generation DCN6 GPU code accounting for roughly one-third of the patch. Linux 7.3-rc1 is intended for testing and is not yet a stable release.lkml.org ↗
BioNTech and Genentech will terminate a Phase 2 trial of the personalized mRNA cancer therapy autogene cevumeran in patients with surgically resected, high-risk colorectal cancer. An independent monitoring board identified a numerical imbalance in overall survival and concluded that continuing the study was unlikely to change its efficacy outcome. BioNTech said no new safety signal was detected and a separate pancreatic cancer trial will continue as planned. BioNTech resmî açıklaması ↗biontech.com ↗
MIT reported that Julia, the programming language that began as an institute research project, now has more than one million users worldwide. The open-source language is used for scientific research, data analysis and modelling complex systems ranging from medicines to aircraft. JuliaHub’s Dyad 3.0 platform also uses AI agents that account for physical laws during engineering design.news.mit.edu ↗
